Licensing Elixira grants access to a patent-protected platform designed for long-term impact and responsible scalability. Rather than replacing existing healthcare systems, Elixira integrates seamlessly—enhancing what is already there with autonomous, preventive intelligence.
Licensees receive the legal right to implement Elixira within defined territories and applications. The system itself is engineered for seamless integration, adaptation to regulatory frameworks, and long-term expansion across clinical and veterinary domains. Rights are non-exclusive or exclusive depending on region, scope, and alignment with the platform’s ethical and scientific standards.
Access to Elixira Fauna, the veterinary extension, requires a valid license of the human Elixira system and grants tailored rights to implement the technology within approved veterinary frameworks.
Licensing is structured to ensure:
This is not just a license to use a technology.
It is a shared responsibility to redefine how we prevent, detect, and eliminate cancer—together.